Respiratory syncytial virus (RSV) vaccinations

From September 2024, pregnant women, between 28 and 36 weeks, and people aged 75 to 79 will be offered an RSV vaccine to help protect the most vulnerable from the respiratory syncytial virus (RSV), at the recommendation of the JCVI (Joint Committee on Vaccination and Immunisation). 

RSV (respiratory syncytial virus) is a common winter virus, which almost all children have had by the time they are two years old. It is common for older children and adults to have the virus again.  

For most people, RSV causes a mild illness, such as a cough or cold. However, babies under one year of age and older adults are at risk of becoming very unwell. Sometimes, people who get ill from RSV infection need to go to hospital. RSV can be more dangerous for some people, especially those with certain health conditions. It may even cause death. 

For more information about the RSV vaccine, follow this link to the Public Health Wales website.